Arktus Therapeutics Co., Ltd.
PrivateLast Round
Series A
Sep 22, 2025
Total Funding Raised
$7.32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arktus Therapeutics Co., Ltd. is a biotechnology company that develops regenerative medicine for knee cartilage repair using iPS cell and 3D-printing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, 3D Printing, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arktus Therapeutics Co., Ltd. Comparables
Compare Arktus Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BIONCaRT GmbH | 79% | |
| Sumitomo Chemical | 76% | |
| Teijin Limited | 72% | |
Arktus Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2025 | ||||
| Seed | Apr 10, 2024 |
Arktus Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series A |
| Kyoto Capital Partners | Seed, Series A |
| QB Capital | Seed, Series A |
| 株式会社佐銀キャピタル＆コンサルティング | Seed, Series A |
| Kyoto University Innovation Capital | Series A, Seed |
| Japan Science and Technology Agency | Seed, Series A |
| MTG Ventures, Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
Raised $4.46M from multiple venture capital firms.
- Apr 10, 2024
$2.86M round led by Kyoto University Innovation Capital
Arktus Therapeutics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arktus Therapeutics Co., Ltd.'s valuation, stock price, and market status.